首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1673055

按產品類型、治療領域、應用和地區分類的配藥市場

Compounding Pharmacies Market, By Product Type, By Therapeutic Area, By Application, By Geography

出版日期: 2025年02月17日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球複合藥局市場規模估計為 118.9 億美元，預計到 2032 年將達到 182.4 億美元，2025 年至 2032 年的複合年成長率為 6.3%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	118.9億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	6.30%	2032 年金額預測	182.4億美元

數字。 2025 年各地區配藥市場佔有率（%）

由於針對複雜情況的個人化藥物的需求不斷增加，全球複合藥局市場預計將在預測期內呈指數級成長。當食品藥物管理局核准處方箋美國時，配藥藥房會根據患者的特定臨床需求組合和修改成分，以創建定製配方。這些有助於解決精確的劑量要求和特殊配方，例如針對無法吞嚥固態錠劑的兒童或老年患者的藥物。此外，配藥商可以生產具有獨特風味和給藥途徑的藥物，擴大治療選擇。越來越多的老年人被診斷出患有慢性疾病，推動了處方藥的需求。

市場動態

由於全球需要客製化藥物的慢性病發病率不斷增加，全球複合藥局市場正經歷強勁成長。此外，老年人口的不斷成長，往往需要專門的配方和劑型，這也推動了市場的成長。配藥藥房相對於非處方藥的優勢，例如獨特的劑型、兒科劑型以及滿足特定患者需求的能力，也在推動市場成長。然而，嚴格的處方藥法規結構和品質標準可能會阻礙市場的成長。此外，昂貴的商業等價物的供應也可能阻礙市場的成長。新興經濟體醫療保健支出的增加和先進複合技術的利用可能為市場成長提供有利的機會。

研究的主要特點

本報告對全球配藥藥房市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和複合年成長率（CAGR%），以 2024 年為基準年。
它揭示了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球配藥藥局市場的主要企業。
主要企業包括 Avella Specialty Pharmacy、Central Admixture Pharmacy Services、Fagron、Fresenius Kabi AG、PharMEDium Services、Institutional Pharmacy Solutions、Cantrell Drug Company、Triangle Compounding Pharmacies、Lorraine's Pharmacy、Rx3 Compounding Pharmacy、Ban BraLCing Pharmacies、Lorraine's Pharmacy、Rx3 Compounding Pharmacy、BBB.k、B錯誤、Scocy0、Saken Pharmacy00000 NpiniS、BasSa)。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球複合藥房市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過分析全球藥局市場所使用的各種策略矩陣來促進決策。

公司簡介
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex

第 10 章分析師建議

興衰
一致的機會地圖

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI3199

Global Compounding Pharmacies Market is estimated to be valued at USD 11.89 Bn in 2025 and is expected to reach USD 18.24 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 11.89 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.30%	2032 Value Projection:	USD 18.24 Bn

Figure. Compounding Pharmacies Market Share (%), By Region 2025

Global compounding pharmacies market is expected to witness growth exponentially over the forecast period, owing to rising demand for personalized medications for complex conditions. Compounding pharmacies combine or alter ingredients into customized formulations as per patient's specific clinical needs when an U.S. Food and Drug Administration approved prescription product is not available. These help to cater accurate dosing requirements and particular formulations like medications for pediatric or geriatric patients who cannot swallow solid pills. Moreover, the ability of compounders to produce medications with unique flavors and routes of administration expands treatment options. Growing geriatric population diagnosed with chronic health conditions boosts demand for compounded medications.

Market Dynamics:

Global compounding pharmacies market is witnessing robust growth due to increasing incidence of chronic medical conditions worldwide requiring customized medications. Moreover, growing geriatric population base that often need specialized formulations and dose forms of drugs can drive the market growth The advantages of compounding pharmacies over commercially available drugs including unique dosage forms, pediatric dose forms, and ability to cater to patient-specific needs can also drive the market growth. However, strict regulatory framework and quality standards for compounded drugs can hamper the market growth. The availability of expensive commercial equivalents can also hamper the market growth. Increasing healthcare expenditure in emerging nations and utilization of advanced technologies in compounding can offer lucrative opportunities for the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global compounding pharmacies market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun SE, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, Advanced Pharmacy.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global compounding pharmacies market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market.

Detailed Segmentation-

By Product Type:
- Oral
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Nasal
- Ophthalmic
By Therapeutic Area:
- Hormone Replacement Therapy
- Pain Management
- Specialty Drugs
- Nutritional Supplements
- Others
By Application:
- Pediatric
- Adults
- Geriatrics
- Veterinary
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Compounding Pharmacies Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Compounding Pharmacies Market, By Product Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Capsule
Tablets
Mixtures
Lollipops
Lozenges
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gels
Ointments
Cream
Lotions
Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Compounding Pharmacies Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hormone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutritional Supplements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Compounding Pharmacies Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Veterinary
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Compounding Pharmacies Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Avella Specialty Pharmacy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Central Admixture Pharmacy Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fagron
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fresenius Kabi AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex